Teva Pharmaceutical Industries, Ltd.
Records under this name other than the patents Teva Pharmaceutical Industries, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.
Back to Teva Pharmaceutical Industries, Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,625,946 | Propargylated Aminoindans, Processes for Preparation, and Uses Thereof In force · High confidence | In force | High confidence | |
| US 8,124,644 | Carvedilol Phosphate now held by Assia Chemical Industries Ltd. In force · Medium confidence | In force | Medium confidence | |
| US 7,989,473 | Stable Laquinimod Preparations now held by Active Biotech, AB In force · High confidence | In force | High confidence | |
| US 9,340,307 | Stable Laquinimod Preparations now held by Active Biotech, AB In force · Low confidence | In force | Low confidence | |
| US 8,158,146 | Stable Combinations of Amlodipine Besylate and Benazepril Hydrochloride now held by Teva Pharmaceuticals USA, Inc. In force · High confidence | In force | High confidence | |
| US 8,865,722 | Wet formulations of aripiprazole held via Teva Pharmaceuticals USA, Inc. In force · High confidence | In force | High confidence | |
| US 8,367,105 | Compressed Solid Dosage Form Manufacturing Process Well-Suited for Use with Drugs of Low Aqueous Solubility and Compressed Solid Dosage Forms Made Thereby held via Teva Pharmaceuticals USA, Ltd. In force · Medium confidence | In force | Medium confidence | |
| US 8,178,127 | Stable Laquinimod Preparations now held by Active Biotech, AB In force · High confidence | In force | High confidence | |
| US 8,414,918 | Stable Imatinib Compositions held via Teva Pharmaceuticals USA, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 8,722,722 | Raltegravir Salts and Crystalline Forms Thereof now held by Assia Chemical Industries Ltd. In force · Medium confidence | In force | Medium confidence |